Work

Abstract 708: Phase I clinical trial to target oxidative phosphorylation and CREB for children and young adults with relapsed or refractory AML

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-708

Authors: Kailen Mark, Norman Lacayo, Kathleen M. Sakamoto

Institution: Stanford University

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409690514

Cites:

Cited by:

Related to: 10